Xueqing Dou

机构：Soochow University, National Clinical Research, First Affiliated Hospital of Soochow University · ORCID：0000-0003-3304-0079

发表论文 36 篇 · 总被引 266 次 · h-index 10

代表论文

• Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML (2025 · Blood · 被引 49)
• Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial (2024 · Signal Transduction and Targeted Therapy · 被引 33)
• Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial (2024 · Journal of Hematology & Oncology · 被引 17)
• Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China (2022 · Haemophilia · 被引 12)
• Demographics, clinical profile and treatment landscape of patients with haemophilia B in China (2022 · Haemophilia · 被引 10)
• Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia (2024 · Blood Cancer Journal · 被引 8)